Companies /Healthcare

Johnson & Johnson

NYSE: JNJ Drug Manufacturers - General
$251.79
▲ $3.18 (+1.28%) today
Markets open · 11:21am ET

24/7 Wall St. View

Price Prediction $286.56 +16.5% Our analysts’ 12-month view: target, optimistic case, and floor. JNJ price prediction → Earnings EPS vs. the estimate, revenue, and how the market reacted. JNJ earnings history →

JNJ at a Glance

Valuation
Market cap
$599.1B
P/E ratio
28.8
Dividend yield
1.99%
Profitability
Revenue (TTM)
$97.9B
Profit margin
21.5%
EPS (TTM)
$8.63
Price
52-week range
$181 – $281
24/7 target
$286.56
Street target
$279.82

Headquartered in New Brunswick, NJ Fiscal year ends December NYSE: JNJ jnj.com

About Johnson & Johnson

Johnson & Johnson is a global healthcare company operating through two business segments: Innovative Medicine and MedTech. The Innovative Medicine segment develops and commercializes therapies across oncology (DARZALEX, CARVYKTI, TECVAYLI, TALVEY, RYBREVANT/LAZCLUZE, ERLEADA, IMBRUVICA), immunology (TREMFYA, STELARA, SIMPONI/SIMPONI ARIA, REMICADE), neuroscience (SPRAVATO, CAPLYTA, INVEGA SUSTENNA/XEPLION/INVEGATRINZA/TREVICTA, CONCERTA), pulmonary hypertension (OPSUMIT/OPSYNVI, UPTRAVI), infectious diseases (EDURANT, PREZISTA/SYMTUZA), and cardiovascular/metabolism (XARELTO). The MedTech segment encompasses cardiovascular devices (electrophysiology products, Abiomed heart support, Shockwave intravascular lithotripsy), surgical instruments and solutions (advanced and general surgery), vision care (contact lenses and surgical ophthalmology), and orthopaedics (hips, knees, trauma, spine, and sports medicine). The company is in the process of planning a separation of its Orthopaedics business. Johnson & Johnson trades on the NYSE under the ticker JNJ and serves healthcare professionals and patients in markets worldwide. Updated

Latest Activity

Jim Cramer
PodcastMad Money w/ Jim CramerJim Cramer · 44 min

Mad Money w/ Jim Cramer 10/13/26

  • Semis called the market's ball and chain: the VanEck chip ETF fell 7.22% over six sessions, its worst streak since May of last year
  • Cramer says Micron's China memory fears are overblown, pointing to 26 long-term take-or-pay contracts running to 2030
  • Apple stays a buy into the foldable two-screen iPhone, with new Siri devices driving memory and CPU demand
  • Wells Fargo should have been a winner on Charlie Scharf's rate-sensitive setup and next-year guidance

The call is to ignore the chip tape and look at where the silicon actually goes: Cramer argues Micron and AMD demand is real even as Korean memory pricing drags the whole group lower. He also thinks the bank selloff mispriced Wells Fargo, which makes more money if rates keep climbing.

Read more
JNJJohnson & Johnson
Regular session
$245.87
-3.38%open $254.46

A 3.4% slide to $245.87 is an outsized single day for a $592 billion defensive name, and it lands with earnings due today. The report arrives with the stock already repriced.

Read more
JNJJohnson & Johnson
Reports Tue Oct 13Before open6:20 AM ETConfirmed

Johnson & Johnson reports at 6:20 AM ET with consensus at $2.50 in EPS on $25.38 billion in revenue. The guidance commentary on talc settlement costs and device demand is what moves the stock.

    Read more
    Earnings on deck — Oct 12–16
    51 companies38 before open13 after close

    Q3 earnings season front-loads everything into two mornings: JPMorgan, Goldman, Wells Fargo, Citi, UnitedHealth and Johnson & Johnson all report before the open Tuesday, with Bank of America, Morgan Stanley, BlackRock and ASML following Wednesday. Of 51 companies on the week, 38 land before the bell, so the tone for rates, credit and chip demand gets set early.

    • UNHUnitedHealth Group IncorporatedTue Oct 13Before open
    • JPMJPMorgan Chase & Co.Tue Oct 13Before open
    • GSThe Goldman Sachs Group, Inc.Tue Oct 13Before open
    • WFCWells Fargo & CompanyTue Oct 13Before open
    • DPZDomino's Pizza, Inc.Tue Oct 13Before open
    • JNJJohnson & JohnsonTue Oct 13Before open
    • CCitigroup Inc.Tue Oct 13Before open
    • ACIAlbertsons Companies, Inc.Tue Oct 13Before open
    • FBKFB Financial CorporationTue Oct 13Before open
    • AZZAZZ Inc.Tue Oct 13After close
    • ASMLASML Holding N.V.Wed Oct 14Before open
    • BACBank of America CorporationWed Oct 14Before open
    • MSMorgan StanleyWed Oct 14Before open
    • BLKBlackRock, Inc.Wed Oct 14Before open
    • PGRProgressive CorporationWed Oct 14Before open
    Read more
    Jim Cramer
    PodcastMad Money w/ Jim CramerJim Cramer · 44 min

    Mad Money w/ Jim Cramer 10/5/26

    • Cramer flags a broken pattern: oil fell while the 30-year yield climbed to 5.66%, near 6%
    • Nasdaq's record close carried by Microsoft on Copilot, Meta's small-business ad shift, and Nvidia's all-time high
    • Saudis discounting crude $5 below the Oman/Dubai benchmark is market share defense, not a fading war premium
    • Caller questions on Intuitive Surgical as a broken stock, plus KLA, Domino's and SoFi

    Cramer's warning: strip out Microsoft, Nvidia and Meta and the safety names were hit, meaning three stocks are carrying the index. He says the bond market tells the truth longer term, and the 30-year at 5.66% caps any broad rally. Owning the hyperscalers has been the only trade that worked.

    Read more
    House trade disclosureThomas H. Kean, Jr.
    • GOOGLAlphabet Inc. - Class A Common Stock (GOOGL)Partial sell$1K – $15KAug 27
    • AMCRState Street Bank & Trust Co. Amcor plc Ordinary Shares (AMCR)Partial sell$1K – $15KAug 10
    • JNJKean Family Partnership Johnson & Johnson Common Stock (JNJ)Partial sell$1K – $15KAug 27
    • LINState Street Bank & Trust Co. Linde plc - Ordinary Shares (LIN)Buy$1K – $15KAug 10
    • MTZKean Family Partnership MasTec, Inc. Common Stock (MTZ)Buy$1K – $15KAug 21
    • MSFTKean Family Partnership Microsoft Corporation - Common Stock (MSFT)Partial sell$15K – $50KAug 27
    Made public 33 days after the earliest trade

    Kean trimmed megacap tech on the same August day, with the Microsoft sale the largest line in the filing, and rotated the proceeds toward industrial gas and infrastructure names. Disclosed 33 days after the trades, so the rotation out of Big Tech and into picks-and-shovels was already done before anyone could see it.

    Read more

    JNJ Coverage

    Load More

    Frequently Asked Questions

    What does Johnson & Johnson do?

    Johnson & Johnson is a global healthcare company operating through two business segments: Innovative Medicine and MedTech.

    What is the JNJ stock price target?

    24/7 Wall St.'s 12-month price target for JNJ is $286.56, rated Buy. The Wall Street consensus target is $279.82. JNJ price prediction →